Division of Emergency Medicine (J.T.H.), Duke University School of Medicine, Durham, NC.
Duke Global Health Institute (J.T.H., S.G., S.P., N.M.T., G.S.B.), Duke University, Durham, NC.
Circ Cardiovasc Qual Outcomes. 2022 Apr;15(4):e008528. doi: 10.1161/CIRCOUTCOMES.121.008528. Epub 2022 Mar 18.
Little is known about long-term outcomes and uptake of secondary preventative therapies following acute myocardial infarction (AMI) in sub-Saharan Africa.
Consecutive patients presenting with AMI (as defined by the Fourth Universal Definition of AMI Criteria) to a northern Tanzanian referral hospital were enrolled in this prospective observational study. Follow-up surveys assessing mortality, medication use, and rehospitalization were administered at 3, 6, 9, and 12 months following initial presentation, by telephone or in person. Multivariate logistic regression was performed to identify baseline clinical and sociodemographic factors associated with one-year mortality.
Of 152 enrolled patients with AMI, 5 were lost to one-year follow-up (96.7% retention rate). Mortality rates were 34.9% (53 of 152 participants) during the initial hospitalization, 48.7% (73 of 150 patients) at 3 months, 52.7% (78 of 148 patients) at 6 months, 55.4% (82 of 148 patients) at 9 months, and 59.9% (88 of 147 patients) at one year. Of 59 patients surviving to one-year follow-up, 43 (72.9%) reported persistent anginal symptoms, 5 (8.5%) were taking an antiplatelet, 8 (13.6%) were taking an antihypertensive, 30 (50.8%) had been rehospitalized, and 7 (11.9%) had ever undergone cardiac catheterization. On multivariate analysis, one-year mortality was associated with lack of secondary education (odds ratio, 0.26 [95% CI, 0.11-0.58]; =0.001), lower body mass index (odds ratio, 0.90 [95% CI, 0.82-0.98]; =0.015), and higher initial troponin (odds ratio, 1.30 [95% CI, 1.05-1.80]; =0.052).
In northern Tanzania, AMI is associated with high all-cause one-year mortality and use of evidence-based secondary preventative therapies among AMI survivors is low. Interventions are needed to improve AMI care and outcomes.
在撒哈拉以南非洲,人们对于急性心肌梗死(AMI)后的长期预后和二级预防治疗的应用知之甚少。
本前瞻性观察性研究纳入了在坦桑尼亚北部一家转诊医院就诊的符合第四版 AMI 定义标准的 AMI 患者。在初次就诊后的 3、6、9 和 12 个月,通过电话或当面进行随访调查,评估死亡率、药物使用和再住院情况。采用多变量逻辑回归分析确定与一年死亡率相关的基线临床和社会人口学因素。
在纳入的 152 例 AMI 患者中,有 5 例在一年随访时失访(96.7%的保留率)。在初次住院期间的死亡率为 34.9%(53/152 例患者),3 个月时为 48.7%(73/150 例患者),6 个月时为 52.7%(78/148 例患者),9 个月时为 55.4%(82/148 例患者),1 年时为 59.9%(88/147 例患者)。在存活至一年随访的 59 例患者中,43 例(72.9%)报告持续有胸痛症状,5 例(8.5%)服用抗血小板药物,8 例(13.6%)服用降压药,30 例(50.8%)再住院,7 例(11.9%)曾接受过心脏导管检查。多变量分析显示,一年死亡率与缺乏中等教育(比值比,0.26[95%置信区间,0.11-0.58];=0.001)、较低的体重指数(比值比,0.90[95%置信区间,0.82-0.98];=0.015)和较高的初始肌钙蛋白(比值比,1.30[95%置信区间,1.05-1.80];=0.052)相关。
在坦桑尼亚北部,AMI 患者的全因一年死亡率较高,AMI 幸存者应用循证二级预防治疗的比例较低。需要采取干预措施来改善 AMI 患者的治疗和预后。